TheJakartaPost
Please Update your browser
Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.
Indonesia's health sector: A five-year progress evaluation
Reviewing the lack of progress in meeting the national health targets over the past five year shows that the next government must do more in promotion and funding to improve health development in Indonesia.
Change text size
Gift Premium Articles
to Anyone
Share the best of The Jakarta Post with friends, family, or colleagues. As a subscriber, you can gift 3 to 5 articles each month that anyone can read—no subscription needed!
A health worker vaccinates an infant on Aug. 19 at the Puskesmas (community health center) in South Denpasar, Bali, as part of the government’s stunting prevention program. (Antara/Nyoman Hendra Wibowo)
I
ndonesia will usher in a new government in the coming months, highlighting a need to review the progress made in the last five years, especially in the health sector. This review evaluates the effectiveness and efficiency of implemented programs and aims to assist in formulating strategic plans for the next five years.
Health program evaluations can be approached in two ways. One is to compare actual achievements against the national targets in the 2020-2024 National Medium-Term Development Plan (RPJMN), which serves as a framework for policies, programs and development initiatives based on the President's vision and mission.
The other is to conduct an international comparison of national achievements, which allows Indonesia to know its global standing. This is crucial for setting more realistic programs and targets that align with international standards.
Currently, eight out of the 15 targets set out in the RPJMN have been achieved or are close to being met.
Smoking prevalence among 10- to 18-year-olds has decreased to 7.4 percent, exceeding the target of 8.7 percent. Obesity prevalence among adults over 18 years has also fallen to 15.3 percent, outperforming the target of 21.8 percent.
The infant mortality rate (IMR) is approaching the targeted 16 per 1,000 live births, and is currently at 16.9 per 1,000. The maternal mortality rate (MMR) is projected to reach the target of 183 per 100,000 live births, after reaching 189 per 100,000 in 2022.
Achieving seven of the targets are expected to be challenging. The decrease in stunting prevalence among toddlers is currently at 21.4 percent, well off the targeted 14 percent. HIV incidence remains high at 1.9 per 1,000 people, compared to the targeted 0.8 per 1,000. Tuberculosis (TB) prevalence is also far from the targeted 190 per 100,000 people, and currently stands at 354 per 100,000.
